(HealthDay News) — In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, insulin dose is not associated with cardiovascular (CV) death after adjustment for baseline covariates, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results